Danhong Injection in the Treatment of Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1503 participants.

Also called NCT01677208

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,503 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01677208
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01677208. Randomized; quadruple masking; primary purpose treatment. Start 2013-03-13 (actual); primary completion 2019-03-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Danhong Injection in the Treatment of Acute Ischemic Stroke
Condition
Acute Stroke
Intervention (Drug)
Danhong injection
Intervention (Procedure)
Standard medical care
Intervention (Drug)
placebo
Lead sponsor
China Academy of Chinese Medical Sciences (class: other)
Collaborator
China Food and Drug Administration (class: other government)

Record details

Record id
cardio:ct-nct01677208
Content hash
272e0c234c00ce4214fa09494632c3ad791baf261df1d2b6917f30d7bbd8b617